Biotech

In “America-First Regeneration,” AI Integration and Manufacturing Innovation Will Be Market Winners

New PitchBook report, outlines how upcoming U.S. tariff policies are set to reshape biotech and pharma investment priorities. The analysis anticipates increased focus on domestic manufacturing and AI-enabled R&D platforms. While large pharmaceutical companies may deprioritize M&A in the short...

Google’s AI Co-Scientist: The New Research Partner for Biotech Scientists

Google's AI Co-Scientist is revolutionizing biomedical research by generating and validating groundbreaking hypotheses. Using advanced AI models, it assists scientists in drug repurposing, target discovery, and understanding antimicrobial resistance. The system refines research proposals through self-improving mechanisms, helping to accelerate...

AI Revolutionizes Breast Cancer Screening: New Study Shows Increased Detection Rates and Reduced Workload

The first randomised controlled trial investigating the use of AI in mammography screening shows that AI-supported mammography increased cancer detection by 29% while cutting workload by 44.2%. Early screening data suggests AI enables earlier detection of small, lymph-node negative cancers....

Owkin Doses First Patient in AI-Driven Oncology Drug Development

Two weeks after announcing Owkin K1.0 Turbigo, a cutting-edge operating system to create the first Artificial General Intelligence (AGI) for biology, Owkin achieves a major milestone in AI-driven drug discovery with OKN4395’s first-in-human trial...

Can AI Healthcare Startups Compete with Tech Giants?

Big Tech’s embedding of AI-driven functionalities across healthcare segments poses a serious challenge for startups. Armed with vast resources and data, giants like Alphabet and Apple set high barriers. The question remains: can startups innovate and survive in this competitive...

Riding the Patent Cliff: How Pharma Giants are Navigating the Sea of Expiring Blockbusters

Facing losses of up to $35 billion annually from expiring patents, pharmaceutical leaders Bristol Myers Squibb, Pfizer, and Merck revealed their strategies at the 2025 J.P. Morgan Healthcare Conference. With a focus on pipeline innovation, strategic acquisitions, and operational efficiency,...

Andreessen Horowitz and Eli Lilly Launch $500 Million First-of-Its-Kind Biotech Venture Fund

A unique partnering between a16z and Eli Lilly aims to redefine biotech innovation by fostering early-stage ecosystems through a $500 million venture fund....

EndoStream Medical Acquired by Kaneka Corporation for $100 Million

EndoStream Medical Ltd., an Israeli startup specializing in neurovascular implants, has been acquired by Japan's Kaneka Corporation for $100 million. The deal includes EndoStream's flagship device, Nautilus™, designed for the treatment of cerebral aneurysms. Kaneka forecasts global sales of $140...

Despite the War: Israel’s Biotechnology Investment Landscape Shows Resilience and Innovation in 2024

Israel's health-tech sector secured $1.2 billion in funding in 2024, with digital health leading at $545 million. Major investors such as OrbiMed and OurCrowd drive innovation across biopharma, medical devices, and AI. Despite challenges for early-stage startups, the ecosystem is...
Image by fernando zhiminaicela from Pixabay

Who Will Reign Supreme in Pharma at 2025?

As the biopharma sector gears up for a record-breaking $1 trillion in revenue, Evaluate's analysts forecasts the major players and blockbuster drugs leading the charge. Roche retains its crown as the top drug maker by prescription sales, while Merck’s Keytruda...

2025 Healthcare & Life Sciences Outlook: Driving Innovation Amid Consolidation

As healthcare and life sciences evolve in a post-pandemic world, 2025 is set to be a pivotal year marked by fewer but larger investments, groundbreaking innovations in AI and brain-computer interfaces, and regionally specialized advancements in biopharma and pharmatech. This...
Interesting Read

Biotech

In “America-First Regeneration,” AI Integration and Manufacturing Innovation Will Be Market Winners

New PitchBook report, outlines how upcoming U.S. tariff policies are set to reshape biotech and pharma investment priorities. The analysis anticipates increased focus on domestic manufacturing and AI-enabled R&D platforms. While large pharmaceutical companies may deprioritize M&A in the short...

Google’s AI Co-Scientist: The New Research Partner for Biotech Scientists

Google's AI Co-Scientist is revolutionizing biomedical research by generating and validating groundbreaking hypotheses. Using advanced AI models, it assists scientists in drug repurposing, target discovery, and understanding antimicrobial resistance. The system refines research proposals through self-improving mechanisms, helping to accelerate...

AI Revolutionizes Breast Cancer Screening: New Study Shows Increased Detection Rates and Reduced Workload

The first randomised controlled trial investigating the use of AI in mammography screening shows that AI-supported mammography increased cancer detection by 29% while cutting workload by 44.2%. Early screening data suggests AI enables earlier detection of small, lymph-node negative cancers....

Owkin Doses First Patient in AI-Driven Oncology Drug Development

Two weeks after announcing Owkin K1.0 Turbigo, a cutting-edge operating system to create the first Artificial General Intelligence (AGI) for biology, Owkin achieves a major milestone in AI-driven drug discovery with OKN4395’s first-in-human trial...

Can AI Healthcare Startups Compete with Tech Giants?

Big Tech’s embedding of AI-driven functionalities across healthcare segments poses a serious challenge for startups. Armed with vast resources and data, giants like Alphabet and Apple set high barriers. The question remains: can startups innovate and survive in this competitive...

Riding the Patent Cliff: How Pharma Giants are Navigating the Sea of Expiring Blockbusters

Facing losses of up to $35 billion annually from expiring patents, pharmaceutical leaders Bristol Myers Squibb, Pfizer, and Merck revealed their strategies at the 2025 J.P. Morgan Healthcare Conference. With a focus on pipeline innovation, strategic acquisitions, and operational efficiency,...

Andreessen Horowitz and Eli Lilly Launch $500 Million First-of-Its-Kind Biotech Venture Fund

A unique partnering between a16z and Eli Lilly aims to redefine biotech innovation by fostering early-stage ecosystems through a $500 million venture fund....

EndoStream Medical Acquired by Kaneka Corporation for $100 Million

EndoStream Medical Ltd., an Israeli startup specializing in neurovascular implants, has been acquired by Japan's Kaneka Corporation for $100 million. The deal includes EndoStream's flagship device, Nautilus™, designed for the treatment of cerebral aneurysms. Kaneka forecasts global sales of $140...

Despite the War: Israel’s Biotechnology Investment Landscape Shows Resilience and Innovation in 2024

Israel's health-tech sector secured $1.2 billion in funding in 2024, with digital health leading at $545 million. Major investors such as OrbiMed and OurCrowd drive innovation across biopharma, medical devices, and AI. Despite challenges for early-stage startups, the ecosystem is...
Image by fernando zhiminaicela from Pixabay

Who Will Reign Supreme in Pharma at 2025?

As the biopharma sector gears up for a record-breaking $1 trillion in revenue, Evaluate's analysts forecasts the major players and blockbuster drugs leading the charge. Roche retains its crown as the top drug maker by prescription sales, while Merck’s Keytruda...

2025 Healthcare & Life Sciences Outlook: Driving Innovation Amid Consolidation

As healthcare and life sciences evolve in a post-pandemic world, 2025 is set to be a pivotal year marked by fewer but larger investments, groundbreaking innovations in AI and brain-computer interfaces, and regionally specialized advancements in biopharma and pharmatech. This...

© [2025] TheMed.co.il. All rights reserved.